Cerevel Therapeutics Hldng I shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $23M | 533k | 42.40 |
| 2023-09-30 | $7.1M | 325k | 21.83 |
| 2023-06-30 | $12M | 364k | 31.79 |
| 2023-03-31 | $9.2M | 377k | 24.39 |
| 2022-12-31 | $9.7M | 307k | 31.54 |
| 2022-06-30 | $2.7M | 101k | 26.44 |
| 2022-03-31 | $2.9M | 82k | 35.01 |
| 2021-12-31 | $14M | 422k | 32.42 |
| 2021-09-30 | $15M | 510k | 29.50 |
| 2021-03-31 | $2.6M | 190k | 13.73 |
| 2020-12-31 | $469k | 28k | 16.57 |